Despite lack of available data, Egypt joins others to approve Chinese vaccine
London, Jan. 4, 2020 (AltAfrica)-Chinese covid-19 vaccine developed by Chinese pharma giant Sinopharm has been granted approval (Emergency Authorization ) by the Egyptian government paving way for mass rollout of vaccination in the north African country
The first batch of the Chinese vaccine was delivered to Egypt in December, with further doses expected this month.
Each batch of the vaccine consists of 50,000 doses, and the first group to receive it will be medical workers.
Egypt plans to purchase 40 million doses of Sinopharm, the Chinese vaccine.
Morocco, another African Arab country like Egypt is closer to doing same.
The two countries and Kenya were part of some limited countries that actively participated in the clinical trials of the Chinese vaccine
The Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials in 10 nations.
Aside China, Two Arab nations were the first countries to approve the Chinese COVID-19 vaccine, a significant boost for China’s plans to roll out its vaccines worldwide.
The United Arab Emirates (UAE) approved a vaccine developed by Chinese state-owned Sinopharm on 9 December, and Bahrain followed days later. But researchers say a lack of public data on the safety and efficacy of the vaccine could hinder the company’s plans to distribute the vaccine in a range of other countries.
Egypt has recorded more than 140,000 cases of the covid-19 disease, including 7,800 deaths.
Egypt, the Arab world’s most populous country, has seen a rise in infections in recent weeks amid warnings by the government about a second wave.
Sinopharm’s vaccine relies on a killed virus, similar to how polio immunisations work.
The United States and the United Kingdom have issued emergency authorizations for a COVID-19 vaccine made by Pfizer of New York City and BioNTech of Mainz, Germany